EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trans-Sodium Crocetinate Ameliorates High-Altitude Acute Lung Injury via Modulating EGFR/PI3K/AKT/NF-κB Signaling Axis

Keke Liang iD, Yanlin Ta, Liang Xu, Shuhe Ma, Renjie Wang, Chenrong Xiao, Yue Gao, Maoxing Li

Nutrients · 23.07.2025 · 17 (15) · 2406

DOI: 10.3390/nu17152406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 23.07.2025. Verfasst von Keke Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730013, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Signal Transduction, Acute Lung Injury, Vitamin A. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Outstanding Doctoral Student Project of Gansu Province, The Traditional Chinese Medicine Innovation Team and Talent Support Program Project from National Administration of Traditional Chinese Medicine, Outstanding Doctoral Student Project of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Saffron, a traditional Chinese medicine, is renowned for its pharmacological effects in promoting blood circulation, resolving blood stasis, regulating menstruation, detoxification, and alleviating mental disturbances. Trans-crocetin, its principal bioactive component, exhibits significant anti-hypoxic activity. The clinical development and therapeutic efficacy of trans-crocetin are limited by its instability, poor solubility, and low bioavailability. Conversion of trans-crocetin into trans-sodium crocetinate (TSC) enhances its solubility, stability, and bioavailability, thereby amplifying its anti-hypoxic potential.

Methods

This study integrates network pharmacology with in vivo and in vitro validation to elucidate the molecular targets and mechanisms underlying TSC’s therapeutic effects against high-altitude acute lung injury (HALI), aiming to identify novel treatment strategies.

Results

TSC effectively reversed hypoxia-induced biochemical abnormalities, ameliorated lung histopathological damage, and suppressed systemic inflammation and oxidative stress in HALI rats. In vitro, TSC mitigated CoCl2-induced hypoxia injury in human pulmonary microvascular endothelial cells (HPMECs) by reducing inflammatory cytokines, oxidative stress, and ROS accumulation while restoring mitochondrial membrane potential. Network pharmacology and pathway analysis revealed that TSC primarily targets the EGFR/PI3K/AKT/NF-κB signaling axis. Molecular docking and dynamics simulations demonstrated stable binding interactions between TSC and key components of this pathway. ELISA and RT-qPCR confirmed that TSC significantly downregulated the expression of EGFR, PI3K, AKT, NF-κB, and their associated mRNAs.

Conclusions

TSC alleviates high-altitude hypoxia-induced lung injury by inhibiting the EGFR/PI3K/AKT/NF-κB signaling pathway, thereby attenuating inflammatory responses, oxidative stress, and restoring mitochondrial function. These findings highlight TSC as a promising therapeutic agent for HALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktSignal TransductionAcute Lung InjuryVitamin ACarotenoidsAltitude SicknessNF-kappa BAnimalsPhosphatidylinositol 3-KinasesHumansErbB ReceptorsRatsRats, Sprague-DawleyMaleOxidative StressAltitudeNetwork PharmacologyLungDisease Models, Animal

Stichwörter der Autor:innen

EGFR/PI3K/AKT/NF-κB signaling pathwayhigh-altitude acute lung injurymolecular dynamics simulationnetwork pharmacologytrans-sodium crocetinate

Substanzen

Proto-Oncogene Proteins c-aktNF-kappa BPhosphatidylinositol 3-Kinasestrans-sodium crocetinateErbB ReceptorsVitamin ACarotenoids

Autor:innen und Institutionen

  • College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730013, China.
  • Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

ORCID-Profile: Keke Liang

Förderung

  • The Outstanding Doctoral Student Project of Gansu Province
  • The Traditional Chinese Medicine Innovation Team and Talent Support Program Project from National Administration of Traditional Chinese Medicine
  • Outstanding Doctoral Student Project of Gansu Province
  • Traditional Chinese Medicine Innovation Team
  • National Administration of Traditional Chinese Medicine

Zitieren

APA

Liang, K., Ta, Y., Xu, L., Ma, S., Wang, R., Xiao, C., Gao, Y., & Li, M. (2025). Trans-Sodium Crocetinate Ameliorates High-Altitude Acute Lung Injury via Modulating EGFR/PI3K/AKT/NF-κB Signaling Axis. Nutrients, 17(15), 2406. https://doi.org/10.3390/nu17152406

Vancouver

Liang K, Ta Y, Xu L, Ma S, Wang R, Xiao C, et al. Trans-Sodium Crocetinate Ameliorates High-Altitude Acute Lung Injury via Modulating EGFR/PI3K/AKT/NF-κB Signaling Axis. Nutrients. 2025;17(15):2406. doi:10.3390/nu17152406

BibTeX
@article{Liang2025,
  author = {Liang, Keke and Ta, Yanlin and Xu, Liang and Ma, Shuhe and Wang, Renjie and Xiao, Chenrong and Gao, Yue and Li, Maoxing},
  title = {Trans-Sodium Crocetinate Ameliorates High-Altitude Acute Lung Injury via Modulating EGFR/PI3K/AKT/NF-κB Signaling Axis},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {15},
  pages = {2406},
  doi = {10.3390/nu17152406}
}
Kostenlos starten →